Walgreens Research Development vs Total Operating Expenses Analysis
| WBA Stock | USD 8.30 0.06 0.73% |
Walgreens Boots financial indicator trend analysis is more than just analyzing Walgreens Boots Alliance current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Walgreens Boots Alliance is a good investment. Please check the relationship between Walgreens Boots Research Development and its Total Operating Expenses accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Research Development vs Total Operating Expenses
Research Development vs Total Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Walgreens Boots Alliance Research Development account and Total Operating Expenses. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Walgreens Boots' Research Development and Total Operating Expenses is 0.83. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Walgreens Boots Alliance, assuming nothing else is changed. The correlation between historical values of Walgreens Boots' Research Development and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Walgreens Boots Alliance are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Research Development i.e., Walgreens Boots' Research Development and Total Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.83 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Research Development
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most indicators from Walgreens Boots' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Walgreens Boots Alliance current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At present, Walgreens Boots' Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.21, whereas Selling General Administrative is forecasted to decline to about 18.4 B.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 28.3B | 27.1B | 26.5B | 14.8B | Total Revenue | 132.7B | 139.1B | 147.7B | 155.0B |
Walgreens Boots fundamental ratios Correlations
Click cells to compare fundamentals
Walgreens Boots Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Walgreens Boots fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 87.2B | 81.3B | 90.1B | 96.6B | 81.0B | 85.1B | |
| Short Long Term Debt Total | 40.1B | 33.4B | 35.5B | 33.5B | 32.9B | 34.5B | |
| Other Current Liab | (1M) | 7.3B | 7.9B | 8.4B | 10.1B | 10.6B | |
| Total Current Liabilities | 27.1B | 22.1B | 22.6B | 24.5B | 27.0B | 28.3B | |
| Total Stockholder Equity | 21.1B | 23.8B | 29.4B | 20.0B | 10.4B | 12.2B | |
| Property Plant And Equipment Net | 35.1B | 34.1B | 33.0B | 33.3B | 30.1B | 31.6B | |
| Net Debt | 39.6B | 32.2B | 34.1B | 32.8B | 31.5B | 33.1B | |
| Retained Earnings | 34.2B | 35.1B | 37.8B | 33.1B | 23.3B | 14.4B | |
| Cash | 516M | 1.2B | 1.4B | 728M | 1.3B | 1.1B | |
| Non Current Assets Total | 69.1B | 65.5B | 73.2B | 81.1B | 62.7B | 65.8B | |
| Non Currrent Assets Other | (822M) | 137M | 287M | 2.6B | 1.8B | 1.9B | |
| Cash And Short Term Investments | 516M | 1.2B | 2.5B | 739M | 3.1B | 3.3B | |
| Net Receivables | 7.1B | 5.7B | 5.0B | 5.4B | 4.9B | 2.5B | |
| Common Stock Shares Outstanding | 880.3M | 866.4M | 865.9M | 863.2M | 863.1M | 804.3M | |
| Liabilities And Stockholders Equity | 87.2B | 81.3B | 90.1B | 96.6B | 81.0B | 85.1B | |
| Non Current Liabilities Total | 39.0B | 35.4B | 37.1B | 43.6B | 41.9B | 44.0B | |
| Inventory | 9.5B | 8.2B | 8.4B | 8.3B | 8.3B | 5.3B | |
| Other Current Assets | 1.1B | 974M | 799M | 1.1B | 2.1B | 2.2B | |
| Other Stockholder Equity | (9.3B) | (9.6B) | (9.7B) | (10.1B) | (10.0B) | (9.5B) | |
| Total Liab | 66.0B | 57.5B | 59.7B | 68.1B | 68.9B | 72.3B | |
| Total Current Assets | 18.1B | 15.8B | 16.9B | 15.5B | 18.3B | 9.5B | |
| Short Term Debt | 6.0B | 3.6B | 3.3B | 3.3B | 2.5B | 1.3B | |
| Accounts Payable | 14.5B | 11.1B | 11.3B | 12.6B | 14.1B | 14.8B | |
| Other Liab | 3.8B | 5.3B | 5.0B | 12.4B | 14.3B | 15.0B | |
| Other Assets | 660M | 2.0B | 1.7B | 2.5B | 2.9B | 3.0B | |
| Long Term Debt | 12.2B | 7.7B | 10.6B | 8.1B | 8.0B | 6.0B | |
| Property Plant Equipment | 33.4B | 34.1B | 33.0B | 31.8B | 36.5B | 38.3B | |
| Property Plant And Equipment Gross | 35.1B | 34.1B | 33.0B | 46.2B | 43.0B | 45.1B | |
| Accumulated Other Comprehensive Income | (3.8B) | (2.1B) | (2.8B) | (3.0B) | (2.9B) | (2.8B) | |
| Good Will | 15.3B | 12.4B | 22.3B | 28.2B | 15.5B | 9.9B | |
| Treasury Stock | (19.1B) | (20.6B) | (20.6B) | (20.7B) | (18.6B) | (17.7B) | |
| Intangible Assets | 10.8B | 9.9B | 10.7B | 13.6B | 13.0B | 6.6B | |
| Net Tangible Assets | 20.6B | 1.5B | 26.3B | (23.3B) | (21.0B) | (19.9B) | |
| Deferred Long Term Liab | 1.8B | 1.5B | 1.9B | 1.4B | 1.3B | 1.6B | |
| Long Term Investments | 7.3B | 7.0B | 5.5B | 3.5B | 2.3B | 4.5B | |
| Short Long Term Debt | 3.5B | 1.3B | 1.1B | 918M | 1.5B | 2.6B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.915 | Dividend Share 1.23 | Earnings Share (10.01) | Revenue Per Share 171.079 | Quarterly Revenue Growth 0.06 |
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.